Opexa Therapeutics, Inc. OPXA
No live quote for OPXA yet.
Analyst view
Consensus: hold
Hold
Price target (mean) 1.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
- Strong buy0
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
- 3 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.12 | -0.12 – -0.12 | -0.28 | +57.1% | 0 | 0.0% | 1 |
| Next quarter | -0.12 | -0.12 – -0.12 | -0.09 | -33.3% | 0 | 0.0% | 1 |
| Current year | -0.47 | -0.47 – -0.47 | -0.98 | +52.0% | 0 | 0.0% | 1 |
| Next year | 0.00 | 0.00 – 0.00 | -0.47 | 0.0% | 10.00M | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 27, 2016 | Aegis Capital | Downgrade | — | Hold |
| Oct 27, 2016 | Chardan Capital | Downgrade | — | Neutral |
| Nov 3, 2015 | Chardan Capital | Initiated | — | Buy |
| May 25, 2015 | Maxim Group | Initiated | — | Buy |
| May 29, 2014 | Aegis Capital | Initiated | — | Buy |
| Mar 23, 2014 | Brinson Patrick | Initiated | — | Outperform |